ESLOY 0MSFT 7.08META -0.85HLPR.TO -0.02VDY.TO 0.38VGG.TO -0.01BIP.UN.TO 0.8TOU.TO -0.5
Daily Stock Opinions and Ratings
Stockchase Opinions

Robert FloydSpectral Med IncEDT.TOHOLDAug 03, 2004

Has been in the doldrums. They have to do a better job of marketing the company and letting investors know exactly what they're up to. Haven't had anything strong enough yet to move the company forward.
Robert FloydRobert Floyd
Owned
Unlock Rating
$2.00

Stock price when the opinion was issued

$1.36

As of Jun 23, 2026. Market Open.

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

COMMENT

Spectral Med Inc(EDT.TO)

Apr 20, 2015

There is nothing more powerful than a base breakout, and this had one in February of this year. This one is on a trend line right now and there is absolutely nothing wrong with the chart.

Photo of Keith RichardsKeith RichardsUnlock Rating
$1.12

Stock price when the opinion was issued

$1.36

As of Jun 23, 2026. Market Open.

biotechnologypharmaceutical
WEAK BUY

Spectral Med Inc(EDT.TO)

Jan 07, 2005
Will have to see a development of their Test kits (?) and have been slow in coming.
Photo of Robert FloydRobert Floyd
Owned
Unlock Rating
$1.10

Stock price when the opinion was issued

$1.36

As of Jun 23, 2026. Market Open.

biotechnologypharmaceutical
BUY

Spectral Med Inc(EDT.TO)

Nov 30, 2004
Likes.
Photo of Rob CallanderRob Callander
Owned
Unlock Rating
$1.39

Stock price when the opinion was issued

$1.36

As of Jun 23, 2026. Market Open.

biotechnologypharmaceutical
BUY

Spectral Med Inc(EDT.TO)

Mar 29, 2004
A really neat little company. Good funding of their R&D. They have revenue and operating profits. Agreement with Cardinal will be good for getting tests done in US.
Photo of Rob CallanderRob CallanderUnlock Rating
$2.96

Stock price when the opinion was issued

$1.36

As of Jun 23, 2026. Market Open.

biotechnologypharmaceutical

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

TRI.TO 6.34$114.84
ZTS 0.63$76.52
MSCI 0.1$580.95
NVDA -8.57$200.08
BAC 0.54$57.91

Today's Top Picks

ESLOY 0$96.36
MSFT 7.08$374.42
META -0.85$563
HLPR.TO -0.02$36.38
VDY.TO 0.38$76.2

Popular Articles

Latest Sell Signals

CLS.TO -34.12$499.31
MBGYY 0$12.93
PLTR -3.025$116.475
ATZ.TO -6.21$156.35
AC.TO 0.25$24.2

Most Recent Experts

Paul Harris, CFA

Paul Harris, CFA

Harris Douglas Asset Management

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Jim Lebenthal

Jim Lebenthal

Cerity Partners

Joe Terranova

Joe Terranova

Virtus Investment Partners

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automatically